448 related articles for article (PubMed ID: 33951350)
1. Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease.
Buisson A; Nancey S; Manlay L; Rubin DT; Hebuterne X; Pariente B; Fumery M; Laharie D; Roblin X; Bommelaer G; Pereira B; Peyrin-Biroulet L; Vuitton L;
United European Gastroenterol J; 2021 Jun; 9(5):552-560. PubMed ID: 33951350
[TBL] [Abstract][Full Text] [Related]
2. Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn's Disease.
Gisbert JP; Chaparro M
Drugs; 2023 Sep; 83(13):1179-1205. PubMed ID: 37505446
[TBL] [Abstract][Full Text] [Related]
3. Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease.
Boube M; Laharie D; Nancey S; Hebuterne X; Fumery M; Pariente B; Roblin X; Peyrin-Biroulet L; Minet-Quinard R; Pereira B; Bommelaer G; Buisson A;
Dig Liver Dis; 2020 Jul; 52(7):740-744. PubMed ID: 32444250
[TBL] [Abstract][Full Text] [Related]
4. Rate and risk factors of postoperative endoscopic recurrence of moderate- to high-risk Crohn's disease patients - A real-world experience from a Middle Eastern cohort.
Azzam N; AlRuthia Y; Al Thaher A; Almadi M; Alharbi O; Altuwaijri M; Alshankiti S; Alanazi M; Alanazi A; Aljebreen A; Regueiro M
Saudi J Gastroenterol; 2022; 28(3):201-208. PubMed ID: 35042320
[TBL] [Abstract][Full Text] [Related]
5. Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies.
Rivière P; Vermeire S; Irles-Depe M; Van Assche G; Rutgeerts P; Denost Q; Wolthuis A; D'Hoore A; Laharie D; Ferrante M
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):713-720.e1. PubMed ID: 32272248
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
Papamichael K; Archavlis E; Lariou C; Mantzaris GJ
J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843
[TBL] [Abstract][Full Text] [Related]
7. Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial.
Bommelaer G; Laharie D; Nancey S; Hebuterne X; Roblin X; Nachury M; Peyrin-Biroulet L; Fumery M; Richard D; Pereira B; Goutte M; Buisson A;
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1553-1560.e1. PubMed ID: 31470175
[TBL] [Abstract][Full Text] [Related]
8. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence.
Ferrante M; Papamichael K; Duricova D; D'Haens G; Vermeire S; Archavlis E; Rutgeerts P; Bortlik M; Mantzaris G; Van Assche G;
J Crohns Colitis; 2015 Aug; 9(8):617-24. PubMed ID: 25926532
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial.
López-Sanromán A; Vera-Mendoza I; Domènech E; Taxonera C; Vega Ruiz V; Marín-Jiménez I; Guardiola J; Castro L; Esteve M; Iglesias E; Ceballos D; Martínez-Montiel P; Gisbert JP; Mínguez M; Echarri A; Calvet X; Barrio J; Hinojosa J; Martín-Arranz MD; Márquez-Mosquera L; Bermejo F; Rimola J; Pons V; Nos P;
J Crohns Colitis; 2017 Oct; 11(11):1293-1301. PubMed ID: 28402454
[TBL] [Abstract][Full Text] [Related]
10. Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease.
Macaluso FS; Grova M; Mocciaro F; Di Mitri R; Privitera AC; Distefano ME; Vitello A; Camilleri S; Ferracane C; Pluchino D; Belluardo N; Giangreco E; Fries W; Viola A; Cappello M; D'Amato L; Bertolami C; Ventimiglia M; Renna S; Casà A; D'Antonio E; De Vivo S; Orlando A;
J Gastroenterol Hepatol; 2023 Sep; 38(9):1503-1509. PubMed ID: 37148148
[TBL] [Abstract][Full Text] [Related]
11. Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry.
Mañosa M; Fernández-Clotet A; Nos P; Martín-Arranz MD; Manceñido N; Carbajo A; Hinojosa E; Hernández-Camba A; Muñoz-Pérez R; Boscá-Watts M; Calvo M; Sierra-Ausín M; Sánchez-Rodríguez E; Barreiro-de Acosta M; Núñez-Alonso A; Zabana Y; Márquez L; Gisbert JP; Guardiola J; Sáinz E; Delgado-Guillena P; Busquets D; van Domselaar M; Girona E; Lorente R; Casas-Deza D; Huguet JM; Maestro S; Cabello MJ; Castro J; Iborra M; Cañete F; Calafat M; Domènech E;
Dig Liver Dis; 2023 Jan; 55(1):46-52. PubMed ID: 35948459
[TBL] [Abstract][Full Text] [Related]
12. Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Mañosa M; Cabré E; Bernal I; Esteve M; Garcia-Planella E; Ricart E; Peñalva M; Cortes X; Boix J; Piñol M; Gassull MA; Domènech E
Inflamm Bowel Dis; 2013 Aug; 19(9):1889-95. PubMed ID: 23689809
[TBL] [Abstract][Full Text] [Related]
13. Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection.
Axelrad JE; Li T; Bachour SP; Nakamura TI; Shah R; Sachs MC; Chang S; Hudesman DP; Holubar SD; Lightner AL; Barnes EL; Cohen BL; Rieder F; Esen E; Remzi F; Regueiro M; Click B
Inflamm Bowel Dis; 2023 Jun; 29(6):888-897. PubMed ID: 35905032
[TBL] [Abstract][Full Text] [Related]
14. Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease.
Candia R; Bravo-Soto GA; Monrroy H; Hernandez C; Nguyen GC
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012328. PubMed ID: 32746500
[TBL] [Abstract][Full Text] [Related]
15. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385
[TBL] [Abstract][Full Text] [Related]
16. Addition of mesalazine for subclinical post-surgical endoscopic recurrence of Crohn's disease despite preventive thiopurine therapy: A case-control study.
Zabana Y; Mañosa M; Cabré E; Bernal I; Marín L; Lorenzo-Zúñiga V; Moreno V; Boix J; Domènech E
J Gastroenterol Hepatol; 2014; 29(7):1413-7. PubMed ID: 24627958
[TBL] [Abstract][Full Text] [Related]
17. Prevention of post-operative recurrence of Crohn's disease among patients with prior anti-TNFα failure: A retrospective multicenter study.
Le Cosquer G; Altwegg R; Rivière P; Bournet B; Boivineau L; Poullenot F; Bozon A; Buscail L; Laharie D; Gilletta C
Dig Liver Dis; 2023 Jun; 55(6):727-734. PubMed ID: 36192340
[TBL] [Abstract][Full Text] [Related]
18. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
Gordon M; Taylor K; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
[TBL] [Abstract][Full Text] [Related]
19. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.
Aguas M; Bastida G; Cerrillo E; Beltrán B; Iborra M; Sánchez-Montes C; Muñoz F; Barrio J; Riestra S; Nos P
World J Gastroenterol; 2012 Aug; 18(32):4391-8. PubMed ID: 22969204
[TBL] [Abstract][Full Text] [Related]
20. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
